Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study.

Chantal B E M Reusken1 Bart L Haagmans Marcel A Müller Carlos Gutierrez Gert-Jan Godeke Benjamin Meyer Doreen Muth V Stalin Raj Laura Smits-De Vries Victor M Corman Jan-Felix Drexler Saskia L Smits Yasmin E El Tahir Rita De Sousa Janko van Beek Norbert Nowotny Kees van Maanen Ezequiel Hidalgo-Hermoso Berend-Jan Bosch Peter Rottier Albert Osterhaus Christian Gortázar-Schmidt Christian Drosten Marion P G Koopmans
Affiliations 1 institutions
  1. Centre for Infectious Disease Research, Diagnostics and Screening, Division Virology, National Institute for Public Health and the Environment, Bilthoven, Netherlands. Electronic address: [email protected].

Abstract

A new betacoronavirus-Middle East respiratory syndrome coronavirus (MERS-CoV)-has been identified in patients with severe acute respiratory infection. Although related viruses infect bats, molecular clock analyses have been unable to identify direct ancestors of MERS-CoV. Anecdotal exposure histories suggest that patients had been in contact with dromedary camels or goats. We investigated possible animal reservoirs of MERS-CoV by assessing specific serum antibodies in livestock. We took sera from animals in the Middle East (Oman) and from elsewhere (Spain, Netherlands, Chile). Cattle (n=80), sheep (n=40), goats (n=40), dromedary camels (n=155), and various other camelid species (n=34) were tested for specific serum IgG by protein microarray using the receptor-binding S1 subunits of spike proteins of MERS-CoV, severe acute respiratory syndrome coronavirus, and human coronavirus OC43. Results were confirmed by virus neutralisation tests for MERS-CoV and bovine coronavirus. 50 of 50 (100%) sera from Omani camels and 15 of 105 (14%) from Spanish camels had protein-specific antibodies against MERS-CoV spike. Sera from European sheep, goats, cattle, and other camelids had no such antibodies. MERS-CoV neutralising antibody titres varied between 1/320 and 1/2560 for the Omani camel sera and between 1/20 and 1/320 for the Spanish camel sera. There was no evidence for cross-neutralisation by bovine coronavirus antibodies. MERS-CoV or a related virus has infected camel populations. Both titres and seroprevalences in sera from different locations in Oman suggest widespread infection. European Union, European Centre For Disease Prevention and Control, Deutsche Forschungsgemeinschaft.

Supporting text Virus Host Location
Animals 1948 Antibodies, Neutralizing 80 Antibodies, Viral 212 Camelids, New World 6 Camelus 39 Cattle 126 Coronavirus 92 Female 289 Goats 24 Humans 1440 Immunoglobulin G 24 Male 224 Sheep 34

Evidence records

2 total
Zoonotic Surveillance
2 records · 1 evidence types
Evidence type
2 records
OVE1540
Key finding

All tested Omani dromedary camels and 14% of Spanish dromedary camels had antibodies against the MERS-CoV spike protein.

Virus
Host
Location
Not specified
Supporting text

50 of 50 (100%) sera from Omani camels and 15 of 105 (14%) from Spanish camels had protein-specific antibodies against MERS-CoV spike.

Method
protein microarray | virus neutralisation test
Sample type
sera
OVE1541
Key finding

Omani camel sera had high MERS-CoV neutralising antibody titres ranging from 1/320 to 1/2560, while Spanish camel sera showed lower titres between 1/20 and 1/320.

Virus
Host
Location
Not specified
Supporting text

MERS-CoV neutralising antibody titres varied between 1/320 and 1/2560 for the Omani camel sera and between 1/20 and 1/320 for the Spanish camel sera.

Method
virus neutralisation test
Sample type
sera